Sponsor Pipeline

Ji Yongling Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-04 NCT07744074 Phase I Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Tumors Recruiting
Active Trials by Phase
Phase 2
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06379087 Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for… Non-Small Cell Lung Cancer Recruiting
NCT07385664 Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC Resectable Esophageal Cancer Not Yet Recruiting
Not specified
NCT07744074 Phase I Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Tumors Carbon Ion Radiotheray Recruiting
NCT07035860 Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable… Carbon Ion Radiotheray Not Yet Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Esophageal Cancer (1)
Get alerts when Ji Yongling's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free